Sort
130,381 grants matching “hiv”
TOWARDS A MORE RELEVANT MODEL OF HIV INFECTION
$880,000Julie M Overbaugh · Fred Hutchinson Cancer Research Center · DP1 · FY2019 · DA
TOWARDS A MORE RELEVANT MODEL OF HIV INFECTION
$880,000Julie M Overbaugh · Fred Hutchinson Cancer Research Center · DP1 · FY2015 · DA
TOWARDS A MORE RELEVANT MODEL OF HIV INFECTION
$880,000Julie M Overbaugh · Fred Hutchinson Cancer Research Center · DP1 · FY2018 · DA
Massachusetts HIV and Justice-Involved Populations Research Network
$879,922Alysse Gail Wurcel · Boston Medical Center · R61 · FY2024 · DA
Short-term and long-term effects of methamphetamine exposure on residual viral transcription during treated HIV disease
$879,803Sulggi Angela Lee · University Of California, San Francisco · R33 · FY2024 · DA
HIV-1 Fusion Peptide-directed Vaccine Design Using Virus-like Particles
$879,691Rui Kong · Emory University · R01 · FY2025 · AI
LONG-TERM CAPACITY FOR HIV PREVENTION EDUCATION TO YOUTH
$879,634Albert York · Hope Educational Foundation · U2G · FY2010 · PS
Clinical Pharmacology & Analytical Chemistry Core
$879,623Angela D Kashuba · Univ Of North Carolina Chapel Hill · P30 · FY2013 · AI
Population genotyping of the germline immunoglobulin repertoire in AIDS-designated rhesus macaque breeding colonies
$879,617Steven Edward Bosinger · Emory University · R24 · FY2025 · AI
Improving Quality of Care for the Treatment of Childhood Pneumonia
$879,558Patricia L Hibberd · Massachusetts General Hospital · U01 · FY2012 · HD
Recognition Of HIV Envelope gp120 by Siglec and C-type Lectin Receptors
$879,512Peter D. Sun · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Measuring and Monitoring Adherence to ART with Pill Ingestion Sensor System
$879,497Honghu Liu · University Of California Los Angeles · R01 · FY2016 · MH
The role of PrEP in Getting to Zero
$879,455Daniel Escudero · Vanderbilt University Medical Center · R01 · FY2023 · AI
Mediators of fatty liver disease during HIV/SIV and cART treatment
$879,420Donald L Sodora · Seattle Children'S Hospital · R01 · FY2022 · AI
Mediators of fatty liver disease during HIV/SIV and cART treatment
$879,420Donald L Sodora · Seattle Children'S Hospital · R01 · FY2021 · AI
Brief Strategic Family Therapy versus Treatment as Usual: Extended Follow-up for
$879,405Jose Szapocznik · University Of Miami School Of Medicine · RC2 · FY2009 · DA
Design Strategies for Film Dosing Forms
$879,322Lisa C Rohan · Magee-Women'S Res Inst And Foundation · U19 · FY2019 · AI
Role of integrins in HIV/SIV transmission across cervico-vaginal mucosa
$879,267Elena Martinelli · Population Council · R01 · FY2012 · AI
Role Of Monocytes In AIDS And As Targets For Antiviral Therapy
$879,248Sharon M Wahl · National Institute Of Dental & Craniofacial Research · ZIA · FY2009 · DE
Health and Aging in Africa: Longitudinal Studies of INDEPTH Communities
$879,205Lisa F Berkman · Harvard School Of Public Health · P01 · FY2015 · AG
Multilevel Comprehensive HIV Prevention for South African Adolescent Girls and Young Women
$879,200Geri R Donenberg · University Of Illinois At Chicago · UH3 · FY2021 · HD
Genomic Sequencing to Establish a Macaque Genotype and Phenotype Research Resource
$879,197Betsy M Ferguson · Oregon Health & Science University · R24 · FY2016 · OD
Impact of Immunotherapy on Viral Immunity in Humans
$879,190Raymond T Chung · Massachusetts General Hospital · U19 · FY2021 · AI
Optimizing glycan shield coverage, germline B cell receptor binding and epitope diversity of V2-apex targeted HIV-1 Env immunogens
$879,161Beatrice H Hahn · University Of Pennsylvania · R37 · FY2024 · AI
High-throughput mapping of antigen specificity to B-cell-receptor sequence for characterizing antibody responses in HIV-vaccinated and infected individuals
$879,020Ivelin Georgiev · Vanderbilt University Medical Center · R01 · FY2020 · AI